Chun-Ying Luo
Overview
    Explore the profile of Chun-Ying Luo including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              8
            
            
              Citations
              18
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Sang Y, Luo C, Huang B, Wu S, Shu J, Lan C, et al.
  
  
    Cell Death Dis
    . 2024 Sep;
          15(9):700.
    
    PMID: 39349930
  
  
          Exploring novel targets for non-small cell lung cancer (NSCLC) remains of utmost importance. This study focused on ORC6 (origin recognition complex subunit 6), investigating its expression and functional significance within...
      
2.
        
    
    Luo C, Su W, Jiang H, Luo L, Shen D, Su G
  
  
    Cancer Cell Int
    . 2023 Dec;
          23(1):333.
    
    PMID: 38115111
  
  
          DPY30 belongs to the core subunit of components of the histone lysine methyltransferase complex, which is implicated in tumorigenesis, cell senescence, and other biological events. However, its contribution to colorectal...
      
3.
        
    
    Su W, Mao X, Li S, Luo C, Fan R, Jiang H, et al.
  
  
    Int J Med Sci
    . 2023 Jun;
          20(7):901-917.
    
    PMID: 37324189
  
  
          DPY30, a core subunit of the SET1/MLL histone H3K4 methyltransferase complexes, plays an important role in diverse biological functions through the epigenetic regulation of gene transcription, especially in cancer development....
      
4.
        
    
    Zhao X, Luo C, Zhang J, Yang M, Luo X, Zhao X, et al.
  
  
    Sichuan Da Xue Xue Bao Yi Xue Ban
    . 2022 Jun;
          53(3):504-510.
    
    PMID: 35642162
  
  
          Objective: To establish a method for quantitative analysis of haloacetic acids (HAAs), disinfection byproducts, in tap water with reversed-phase ultra-performance liquid chromatography-quadrupole-orbitrap high resolution mass spectrometry. Methods: Tap water samples...
      
5.
        
    
    Yang M, Zhao X, Luo C, Xu B, Ren J, Luo X, et al.
  
  
    Sichuan Da Xue Xue Bao Yi Xue Ban
    . 2022 Mar;
          53(2):327-334.
    
    PMID: 35332738
  
  
          Objective: To establish a high-performance liquid chromatography orbital trap mass spectrometry (HPLC-Obitrap MS) method for screening 34 common drugs and metabolites in biological samples. Methods: The target analytes in urine...
      
6.
        
    
    Lu J, Wang X, Zhang T, Huang X, Yao J, Wang C, et al.
  
  
    Oncotarget
    . 2017 Nov;
          8(50):87955-87970.
    
    PMID: 29152133
  
  
          Background: Our previous investigations have shown that the variants of X-ray repair complementing 4 (XRCC4) may be involved in hepatocellular carcinoma (hepatocarcinoma) tumorigenesis. This study aimed to investigate the possible...
      
7.
        
    
    Wang L, Pu R, Wang X, Luo C, Zhang L, Zhang X
  
  
    J Chromatogr Sci
    . 2014 Dec;
          53(6):925-31.
    
    PMID: 25480455
  
  
          A comprehensive ultra-high performance liquid chromatography/tandem mass spectrometry (UHPLC/MS/MS) procedure for detection of nine β-agonists in animal-derived food is described. The method was based on enzymatic hydrolysis with β-glucuronidase from...
      
8.
        
    
    Luo C, Wang J, Wang X, Ma H, Shi S, Yu B, et al.
  
  
    Zhonghua Bing Li Xue Za Zhi
    . 2012 Nov;
          41(8):562-3.
    
    PMID: 23157752
  
  
          No abstract available.